TD Cowen Begins Coverage on Soleno Therapeutics (NASDAQ:SLNO)
TD Cowen started coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a research report report published on Monday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $110.00 target price on the stock. Several other brokerages also recently issued reports on SLNO. Robert W. Baird increased their price objective on […]
